|No DDDs have been established in this group because the doses used vary substantially.|
This group comprises general analgesics and antipyretics.
All salicylic acid derivatives except combinations with corticosteroids (M01B) or opioids (N02AJ) are classified in N02BA - Salicylic acid and derivatives, as it is difficult to differentiate between the use of salicylates in rheumatic conditions and other therapeutic uses of salicylates.
All plain ibuprofen preparations are classified in M01A, even if they are only intended for use as pain relief.
There are a number of combined preparations, which contain analgesics and psycholeptics. These are classified in N02, as pain relief must be regarded as the main indication. Analgesics used for specific indications are classified in the respective ATC groups. E.g.:
A03EA - Antispasmodic/psycholeptics/analgesic combinations
M01 - Antiinflammatory and antirheumatic products
M02A - Topical products for joint and muscular pain
M03 - Muscle relaxants
See comments to these groups.
Lidocaine indicated for postherpetic pain is classified in N01BB.
This group comprises preparations used in the treatment of Parkinsons disease and related conditions, including drug-induced parkinsonism.
|The DDDs are based on recommended doses for the long-term treatment of symptoms of Parkinsons disease.|
No separate DDDs are established for oral depot formulations.
The group is divided into therapeutic subgroups:
N05A - Antipsychotics
N05B - Anxiolytics
N05C - Hypnotics and sedatives
This group comprises antidepressants, psychostimulants, nootropics anti-dementia drugs and combinations with psycholeptics.
Antiobesity preparations are classified in A08 - Antiobesity preparations, excl. diet products.
This group comprises other nervous system drugs, which cannot be classified in the preceding 2nd levels in ATC group N.
Last updated: 2016-12-19